Access cutting-edge epilepsy treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Access epilepsy specialists in Orange at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epilepsy treatment provided free
The X-TOLE3 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101 administered as adjunctive therapy in focal-onset seizures.
Sponsor: Xenon Pharmaceuticals Inc.
Check if you qualify for this epilepsy clinical trial in Orange, CA
If you're searching for epilepsy treatment options in Orange, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.